Select Publications
Journal articles
2000, 'The relationship between corrected TIMI frame counts and late survival after myocardial infarction', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 35, pp. 398A - 398A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000085209701528&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2000, 'Occluded infarct-related arteries and clinical events', Progress in Cardiovascular Diseases, 42, pp. 405 - 418, http://dx.doi.org/10.1016/S0033-0620(00)70005-3
,2000, 'Smoking: Back to the future - Again?', European Heart Journal, 21, pp. 1570 - 1571, http://dx.doi.org/10.1053/euhj.2000.2269
,2000, 'Early ST recovery, infarct artery flow and long-term outcome after acute myocardial infarction', Heart, Lung and Circulation, 9, pp. A99 - A99, http://dx.doi.org/10.1046/j.1443-9506.2000.06371.x
,2000, 'Occluded infarct-related arteries and clinical events', Progress in Cardiovascular Diseases, 42, pp. 405 - 418, http://dx.doi.org/10.1053/pcad.2000.6510
,1999, 'Direct thrombin inhibitors as adjuncts to thrombolytic therapy', Current Cardiology Reports, 1, pp. 184 - 191, http://dx.doi.org/10.1007/s11886-999-0021-0
,1999, 'Antithrombin agents as adjuncts to thrombolytic therapy', Journal of Thrombosis and Thrombolysis, 8, pp. 159 - 166, http://dx.doi.org/10.1023/A:1008975216841
,1999, 'Cardiogenic shock complicating myocardial infarction without ST segment elevation: Final report from the SHOCK registry', CIRCULATION, 100, pp. 577 - 577, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083417103038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Cardiogenic shock treated with thrombolytic therapy and intra-aortic balloon gaunter pulsation: A report from the SHOCK trial', CIRCULATION, 100, pp. 370 - 370, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083417101942&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Effect of early revascularization for cardiogenic shock on 1 year mortality: The SHOCK trial results', CIRCULATION, 100, pp. 369 - 369, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083417101937&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Final core laboratory angiographic analysis from the randomized SHOCK trial: Relationship to outcome and treatment effect', CIRCULATION, 100, pp. 370 - 370, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000083417101941&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Four-year survival of patients with acute coronary syndromes without ST- segment elevation and prognostic significance of 0.5-mm ST-segment depression', American Journal of Cardiology, 84, pp. 379 - 385, http://dx.doi.org/10.1016/S0002-9149(99)00319-7
,1999, 'Factor V leiden and prothrombin variant G20210A are associated with myocardial infarction in patients aged < 50 years with no angiographic stenosis > 50%', THROMBOSIS AND HAEMOSTASIS, pp. 448 - 448, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000085665901418&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Severity of ST depression predicts 8 year outcome in acute coronary syndromes', Heart, 81
,1999, 'Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction', American Journal of Cardiology, 83, pp. 164 - 168, http://dx.doi.org/10.1016/S0002-9149(98)00818-2
,1999, 'Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction', Heart, 81, pp. 128 - 133, http://dx.doi.org/10.1136/hrt.81.2.128
,1999, 'Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow', Journal of the American College of Cardiology, 33, pp. 139 - 145, http://dx.doi.org/10.1016/S0735-1097(98)00517-8
,1999, 'Generalization of trial and registry cohort results to individual patients with cardiogenic shock', ACC Current Journal Review, 8, pp. 27 - 30, http://dx.doi.org/10.1016/S1062-1458(99)00035-5
,1999, 'Glycoprotein IIb/IIIa antagonists in acute coronary syndromes: Clinical trials', Cardiology Review, 16, pp. 43 - 53
,1999, 'Waiting times and prioritisation for coronary artery bypass surgery in New Zealand', Heart, 81, pp. 586 - 592, http://dx.doi.org/10.1136/hrt.81.6.586
,1999, 'Hirudin was superior to heparin in preventing CV death, MI and refractory angina, in patients with unstable angina or MI without ST elevation', Evidence-based Cardiovascular Medicine, 3, pp. 68 - 69, http://dx.doi.org/10.1054/ebcm.1999.0223
,1998, 'Inadequate control of lipid levels in patients with a previous myocardial infarction', New Zealand Medical Journal, 111, pp. 464 - 467
,1998, 'Factor V Leiden and prothrombin variant G20210A in patients < 50 years with recent acute myocardial infarction and no angiographic stenoses > 50%', CIRCULATION, 98, pp. 458 - 459, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076594402437&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Four year prognostic influence of 0.5 mm segment depression in acute coronary syndromes', CIRCULATION, 98, pp. 628 - 629, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076594403323&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Impact of thrombolysis, aortic counterpulsation and their combination in cardiogenic shock: The SHOCK Trial Registry', CIRCULATION, 98, pp. 778 - 778, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076594404089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Streptokinase improves survival up to 12 years after myocardial infarction', CIRCULATION, 98, pp. 631 - 631, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000076594403334&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'Results of percutaneous coronary angioplasty in patients <40 years of age', American Journal of Cardiology, 82, pp. 135 - 139, http://dx.doi.org/10.1016/S0002-9149(98)00318-X
,1998, 'Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction', Journal of the American College of Cardiology, 31, pp. 1499 - 1505, http://dx.doi.org/10.1016/S0735-1097(98)00139-9
,1998, 'Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity', American Journal of Cardiology, 81, pp. 665 - 671, http://dx.doi.org/10.1016/S0002-9149(97)01004-7
,1998, 'Lipid modifying therapy for long-term survivors of myocardial infarction', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 31, pp. 318A - 319A, http://dx.doi.org/10.1016/S0735-1097(97)85100-5
,1998, 'Fibrinolysis for acute myocardial infarction in the elderly patient: Is it effective or too dangerous?', American Journal of Geriatric Cardiology, 7, pp. 22 - 27
,1998, 'Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO 2) Study', Australian and New Zealand Journal of Medicine, 28, pp. 551 - 554, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02109.x
,1998, 'Left ventricular function following thrombolytic therapy for myocardial infarction', Journal of Interventional Cardiology, 11, pp. 9 - 18, http://dx.doi.org/10.1111/j.1540-8183.1998.tb00090.x
,1998, 'Low molecular weight heparins in acute ischaemic syndromes', Australian and New Zealand Journal of Medicine, 28, pp. 555 - 557, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02110.x
,1998, 'New antiplatelet agents', Australian and New Zealand Journal of Medicine, 28, pp. 558 - 564, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02111.x
,1998, 'The corrected TIMI frame count. The new gold standard?', Australian and New Zealand Journal of Medicine, 28, pp. 569 - 573, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02113.x
,1998, 'The roles for coronary surgery and angioplasty in the management of patients with stable angina: Evidence and decision making', Journal of Evaluation in Clinical Practice, 4, pp. 93 - 102, http://dx.doi.org/10.1111/j.1365-2753.1998.00003.x
,1998, 'Thrombolytic eligibility', Australian and New Zealand Journal of Medicine, 28, pp. 518 - 524, http://dx.doi.org/10.1111/j.1445-5994.1998.tb02103.x
,1998, 'Lipid modifying therapy for long-term survivors of myocardial infarction', Journal of the American College of Cardiology, 31, pp. 318 - 319, http://dx.doi.org/10.1016/s0735-1097(98)82032-9
,1997, 'Admission troponin T level may predict 90 minute TIMI flow after thrombolysis', CIRCULATION, 96, pp. 1496 - 1496, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997YC88001494&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO)', Circulation, 96, pp. 2155 - 2161, http://dx.doi.org/10.1161/01.CIR.96.7.2155
,1997, 'Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?', New Zealand Medical Journal, 110, pp. 298 - 299
,1997, 'Coronary revascularisation in young adults', European Journal of Cardio-thoracic Surgery, 11, pp. 732 - 738, http://dx.doi.org/10.1016/S1010-7940(97)01153-6
,1997, 'Data on eligibility for thrombolytic treatment can indeed be generalised [4]', British Medical Journal, 314, pp. 301 - 302
,1997, 'Early non-invasive assessment of reperfusion by myocardial protein release patterns', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29, pp. 7912 - 7912, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WF76101628&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'TIMI flow at 3 weeks following myocardial infarction determines long-term mortality in patients randomized to streptokinase or placebo', JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 29, pp. 7152 - 7152, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WF76100289&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Coronary artery patency and survival in clinical trials', Journal of Thrombosis and Thrombolysis, 4, pp. 239 - 250, http://dx.doi.org/10.1023/A:1008894901473
,1997, 'Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome', Journal of Pediatrics, 131, pp. 147 - 150, http://dx.doi.org/10.1016/S0022-3476(97)70139-2
,1997, 'Defective cell mediated immunity in the X-linked hyper immunoglobulin M syndrome.', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 99, pp. 1619 - 1619, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WH14201615&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1996, 'Captopril within 6 hours of streptokinase in patients with reduced TIMI flow improves ventricular function in the area at risk', CIRCULATION, 94, pp. 1100 - 1100, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VN11901098&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,